0,893  0,002  Antimutagenic
0,861  0,005  Caspase 9 stimulant
0,833  0,007  TNF expression inhibitor
0,802  0,004  CTGF expression inhibitor
0,785  0,003  Superoxide dismutase inhibitor
0,778  0,005  Sensitization
0,771  0,006  Chemoprotective
0,769  0,007  GST A substrate
0,741  0,004  Sulfotransferase substrate
0,712  0,005  Amyloid beta aggregation inhibitor
0,721  0,018  Antineoplastic (breast cancer)
0,707  0,005  Free radical scavenger
0,705  0,004  UGT1A3 substrate
0,694  0,005  UGT1A1 substrate
0,692  0,006  Antioxidant
0,705  0,020  Transcription factor NF kappa B inhibitor
0,686  0,005  Antipyretic
0,707  0,029  Apoptosis agonist
0,684  0,009  Aldehyde oxidase inhibitor
0,677  0,002  Succinate dehydrogenase inhibitor
0,684  0,011  Radioprotector
0,672  0,005  Ulceration
0,671  0,008  Vasodilator, peripheral
0,661  0,002  GST P1-1 substrate
0,666  0,012  Antihypercholesterolemic
0,658  0,007  Lipoxygenase inhibitor
0,654  0,006  UGT1A6 substrate
0,649  0,004  Antihypoxic
0,655  0,011  Chemopreventive
0,649  0,008  NOS2 expression inhibitor
0,651  0,016  CYP2C9 substrate
0,634  0,005  Monophenol monooxygenase inhibitor
0,626  0,003  Cystathionine beta-synthase inhibitor
0,633  0,014  Cholesterol antagonist
0,606  0,010  Antipruritic, allergic
0,600  0,012  UGT1A9 substrate
0,587  0,012  AR expression inhibitor
0,578  0,004  VCAM1 expression inhibitor
0,586  0,013  Proliferative diseases treatment
0,575  0,003  Carbonic anhydrase VI inhibitor
0,571  0,004  UGT2B4 substrate
0,576  0,013  Histamine release inhibitor
0,588  0,026  Antileukemic
0,565  0,005  Melanin inhibitor
0,562  0,004  Amylase inhibitor
0,564  0,017  CYP1A2 substrate
0,550  0,005  NOS3 expression enhancer
0,558  0,014  Cardiovascular analeptic
0,559  0,017  Antineoplastic (cervical cancer)
0,552  0,011  FMO1 substrate
0,546  0,006  Antiseptic
0,574  0,034  Antineoplastic (lung cancer)
0,548  0,012  Antiamyloidogenic
0,550  0,015  Apoptosis antagonist
0,530  0,009  Antihypertriglyceridemic
0,533  0,015  Antineoplastic (non-small cell lung cancer)
0,537  0,022  CYP2C19 substrate
0,574  0,061  Antiinflammatory
0,507  0,003  Carbonic anhydrase III inhibitor
0,528  0,027  Prostate cancer treatment
0,515  0,018  Caspase 3 stimulant
0,495  0,007  Skin whitener
0,490  0,010  Peroxidase inhibitor
0,501  0,022  Cardioprotectant
0,506  0,028  Antithrombotic
0,511  0,038  15-Lipoxygenase inhibitor
0,490  0,017  Vasodilator, coronary
0,483  0,013  UDP-glucuronosyltransferase substrate
0,469  0,003  Keratolytic
0,475  0,009  Tubulin antagonist
0,468  0,005  Pneumotoxic
0,462  0,003  Carbonic anhydrase XIII inhibitor
0,468  0,010  Anesthetic general
0,467  0,012  Pyruvate kinase inhibitor
0,480  0,029  CYP2C19 inhibitor
0,453  0,005  Tyrosine 3 hydroxylase inhibitor
0,466  0,019  Hypoglycemic
0,475  0,031  Antineoplastic (ovarian cancer)
0,449  0,008  Platelet adhesion inhibitor
0,470  0,030  CYP2D6 substrate
0,464  0,034  Antiallergic
0,452  0,023  ICAM1 expression inhibitor
0,433  0,004  Histidine decarboxylase inhibitor
0,454  0,027  NOS3 expression inhibitor
0,431  0,007  DNA methyltransferase I inhibitor
0,446  0,029  12-Lipoxygenase inhibitor
0,437  0,021  DNA damaging
0,458  0,042  Antineoplastic (colorectal cancer)
0,419  0,005  Expectorant
0,439  0,026  Mutagenic
0,420  0,008  Antipruritic, non-allergic
0,416  0,007  Antidote
0,428  0,019  Antimitotic
0,412  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,430  0,024  CYP1A2 inhibitor
0,433  0,029  Carcinogenic
0,406  0,003  Choleretic
0,411  0,010  UGT2B7 substrate
0,433  0,034  Antineoplastic (melanoma)
0,421  0,023  Nitric oxide antagonist
0,416  0,019  Antineoplastic (osteosarcoma)
0,419  0,022  Radiosensitizer
0,410  0,017  Antineoplastic (lymphocytic leukemia)
0,435  0,043  Antineoplastic (colon cancer)
0,430  0,040  Teratogen
0,401  0,014  5 Hydroxytryptamine uptake stimulant
0,398  0,011  Genotoxic
0,398  0,011  DNA methylase inhibitor
0,401  0,016  Skin irritative effect
0,409  0,025  Antineoplastic (lymphoma)
0,392  0,009  Protein kinase stimulant
0,411  0,028  Antiprotozoal (Leishmania)
0,426  0,043  Bone diseases treatment
0,418  0,035  Antineoplastic (brain cancer)
0,404  0,023  Calcium channel activator
0,407  0,028  Hypoxia-inducible factor 1 alpha inhibitor
0,383  0,005  Cholesterol synthesis inhibitor
0,383  0,007  Insulin sensitizer
0,384  0,009  UGT2B15 substrate
0,408  0,035  Antiosteoporotic
0,384  0,012  Phospholipase C inhibitor
0,393  0,021  Antiulcerative
0,398  0,027  Tumour necrosis factor alpha release inhibitor
0,375  0,011  Lipid peroxidase inhibitor
0,367  0,006  5-Lipoxygenase inhibitor
0,383  0,023  FMO3 substrate
0,362  0,004  Vanilloid 1 agonist
0,401  0,043  Hepatic disorders treatment
0,375  0,020  Abortion inducer
0,368  0,017  Non-steroidal antiinflammatory agent
0,369  0,019  P-glycoprotein inhibitor
0,426  0,077  Antidiabetic
0,426  0,077  Cyclophilin D inhibitor
0,352  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,366  0,019  GST M1-1 substrate
0,372  0,028  Vasodilator
0,348  0,007  Carcinogenic, group 2B
0,357  0,017  Antihypotensive
0,384  0,043  Spasmolytic
0,440  0,099  Alpha-glucosidase inhibitor
0,344  0,004  Macrophage migration inhibitory factor inhibitor
0,370  0,031  Antidiabetic symptomatic
0,378  0,040  Antineoplastic (glioma)
0,340  0,003  Heat shock protein 70 antagonist
0,345  0,009  Glutathione S-transferase substrate
0,357  0,021  UGT1A4 substrate
0,364  0,028  Transcription factor STAT3 inhibitor
0,339  0,004  Prostaglandin EP2 antagonist
0,377  0,045  Embryotoxic
0,363  0,032  Antineoplastic (renal cancer)
0,361  0,031  Insulysin inhibitor
0,347  0,024  Eye irritation, high
0,359  0,036  Platelet antagonist
0,330  0,009  Chelator
0,335  0,014  Protein-tyrosine phosphatase inhibitor
0,325  0,004  UGT2B10 substrate
0,386  0,066  CYP3A4 substrate
0,327  0,009  M18 aspartyl aminopeptidase inhibitor
0,365  0,048  Lipoprotein disorders treatment
0,336  0,021  Hepatoprotectant
0,329  0,016  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,323  0,013  Antihelmintic (Nematodes)
0,320  0,013  CYP2B6 inhibitor
0,348  0,042  Cytostatic
0,347  0,041  Sodium/bile acid cotransporter inhibitor
0,312  0,006  LDLR expression enhancer
0,358  0,054  Respiratory analeptic
0,337  0,033  Interleukin agonist
0,309  0,007  Xanthine oxidase inhibitor
0,339  0,038  Myocardial infarction treatment
0,336  0,037  Vascular (periferal) disease treatment
0,337  0,041  Interleukin antagonist
0,382  0,085  Antibacterial
0,312  0,018  Interferon gamma antagonist
0,345  0,052  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,300  0,007  Mediator release inhibitor
0,303  0,011  Interleukin 1 antagonist
0,303  0,010  Antifungal enhancer
0,298  0,008  UGT2B1 substrate
0,331  0,041  Transcription factor STAT inhibitor
0,294  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,333  0,045  Antineoplastic (small cell lung cancer)
0,327  0,040  Angiogenesis stimulant
0,334  0,047  Antineoplastic (multiple myeloma)
0,327  0,040  Antineoplastic (glioblastoma multiforme)
0,303  0,017  Neurotrophic factor enhancer
0,296  0,011  UGT2B9 substrate
0,378  0,093  5 Hydroxytryptamine release inhibitor
0,329  0,045  Antineoplastic (endocrine cancer)
0,294  0,010  SULT1A3 substrate
0,292  0,009  Interleukin 1b antagonist
0,283  0,005  Toll-Like receptor 2 antagonist
0,286  0,010  GABA C receptor agonist
0,317  0,047  Cardiodepressant
0,314  0,046  Antineoplastic (liver cancer)
0,271  0,004  Carbonic anhydrase XIV inhibitor
0,275  0,008  Mannose-6-phosphate isomerase inhibitor
0,272  0,007  SULT1A1 substrate
0,324  0,062  Analeptic
0,263  0,004  Carbonic anhydrase V inhibitor
0,297  0,039  Sigma receptor agonist
0,271  0,014  DNA polymerase I inhibitor
0,341  0,086  CYP2C9 inhibitor
0,259  0,005  Beta tubulin antagonist
0,277  0,024  Carcinogenic, group 3
0,270  0,019  Phospholipase A2 inhibitor
0,274  0,024  Tumour necrosis factor antagonist
0,261  0,013  Uterine stimulant
0,260  0,015  Protein-tyrosine phosphatase 1B inhibitor
0,338  0,093  Immunosuppressant
0,254  0,010  Alcohol dehydrogenase substrate
0,309  0,065  Antineoplastic (pancreatic cancer)
0,256  0,012  ATPase inhibitor
0,270  0,027  Antineoplastic (squamous cell carcinoma)
0,246  0,004  Ornithine decarboxylase inhibitor
0,254  0,012  Phobic disorders treatment
0,266  0,026  Restenosis treatment
0,249  0,009  Breast cancer-resistant protein inhibitor
0,291  0,053  Antiglaucomic
0,291  0,053  Cytotoxic
0,245  0,009  Catalase inhibitor
0,256  0,022  Alpha-N-acetylglucosaminidase inhibitor
0,283  0,049  Cyclic AMP phosphodiesterase inhibitor
0,262  0,029  Amyloid beta precursor protein antagonist
0,237  0,005  Glutamate decarboxylase inhibitor
0,291  0,059  Flavin-containing monooxygenase substrate
0,241  0,010  Antirickettsial
0,322  0,092  Stroke treatment
0,237  0,008  Mucolytic
0,265  0,036  Dual specificity phosphatase 3 inhibitor
0,233  0,005  Leukotriene antagonist
0,266  0,040  Peptidyltransferase inhibitor
0,251  0,026  Liver fibrosis treatment
0,229  0,004  Carbonic anhydrase VA inhibitor
0,237  0,012  Microtubule formation inhibitor
0,254  0,030  Nitric-oxide synthase stimulant
0,300  0,076  Antiischemic
0,234  0,009  Beta glucuronidase inhibitor
0,240  0,018  VEGF expression inhibitor
0,252  0,030  Antiacne
0,226  0,004  Glutathione S-transferase inhibitor
0,227  0,007  HIV-1 integrase (Overall Integration) inhibitor
0,226  0,006  Adenylate cyclase stimulant
0,242  0,023  Cyclooxygenase 1 inhibitor
0,229  0,010  Estrogen antagonist
0,243  0,025  Corneal wound healing stimulator
0,225  0,007  ABCA1 expression enhancer
0,227  0,014  Antieczematic
0,227  0,013  Arachidonic acid antagonist
0,269  0,056  DNA synthesis inhibitor
0,230  0,018  Cell adhesion inhibitor
0,271  0,059  Hypolipemic
0,245  0,039  Dual specificity phosphatase inhibitor
0,217  0,011  Dementia treatment
0,210  0,006  Phenylalanine 4-hydroxylase inhibitor
0,287  0,082  Antipsoriatic
0,212  0,011  Vascular dementia treatment
0,204  0,005  Carbonic anhydrase VB inhibitor
0,257  0,058  Antiparasitic
0,223  0,025  Carcinogenic, group 1
0,202  0,004  UGT2B11 substrate
0,218  0,021  Gout treatment
0,219  0,023  Antihyperlipoproteinemic
0,340  0,144  DNA polymerase beta inhibitor
0,200  0,005  HIV-1 integrase inhibitor
0,199  0,004  Antifungal (Pneumocystis)
0,338  0,143  DNA directed DNA polymerase inhibitor
0,242  0,048  Antihelmintic
0,206  0,012  Aldehyde dehydrogenase substrate
0,211  0,017  Carbonic anhydrase XV inhibitor
0,229  0,036  Antineoplastic (carcinoma)
0,197  0,004  Xanthine dehydrogenase inhibitor
0,272  0,079  5 Hydroxytryptamine release stimulant
0,225  0,034  MAO inhibitor
0,197  0,007  Vanilloid agonist
0,193  0,004  Leukotriene B4 antagonist
0,217  0,028  Neurotensin receptor agonist
0,245  0,057  Antineoplastic enhancer
0,278  0,092  Antifungal
0,190  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,192  0,006  Alpha tubulin antagonist
0,212  0,028  Antiprotozoal (Coccidial)
0,211  0,027  Antianemic
0,191  0,008  DOPA decarboxylase inhibitor
0,222  0,040  Acaricide
0,187  0,008  Toll-Like receptor 4 antagonist
0,196  0,020  Cyclooxygenase 3 inhibitor
0,190  0,015  Antispirochetal
0,183  0,008  Aldose reductase inhibitor
0,179  0,005  Transcription factor AP-1 inhibitor
0,204  0,034  Insulin secretagoues
0,249  0,080  Antineoplastic (bladder cancer)
0,183  0,015  TRPA1 agonist
0,243  0,075  Antineoplastic (sarcoma)
0,281  0,113  Thioredoxin glutathione reductase inhibitor
0,229  0,062  Platelet aggregation inhibitor
0,206  0,040  Cyclooxygenase inhibitor
0,205  0,040  Aldehyde oxidase substrate
0,178  0,013  Prolactin inhibitor
0,182  0,017  Gastritis treatment
0,179  0,015  AMP-activated protein kinase stimulant
0,168  0,005  GABA aminotransferase inhibitor
0,212  0,050  Mcl-1 antagonist
0,178  0,016  Uric acid excretion stimulant
0,165  0,004  Prostaglandin EP3 antagonist
0,181  0,022  Coagulant
0,199  0,040  Antineoplastic (bone cancer)
0,221  0,063  Septic shock treatment
0,242  0,089  Gastrin inhibitor
0,194  0,042  Anesthetic
0,197  0,046  Hair growth stimulant
0,164  0,013  Thioredoxin inhibitor
0,180  0,030  Interleukin 4 antagonist
0,187  0,038  Alkaline phosphatase inhibitor
0,188  0,042  Antidiarrheal
0,163  0,017  Actinic keratosis treatment
0,176  0,030  Antihemorrhagic
0,242  0,097  Antidiabetic (type 2)
0,173  0,030  MAO B inhibitor
0,162  0,021  Ca2+-transporting ATPase inhibitor
0,175  0,035  Alkylator
0,216  0,078  RNA-directed DNA polymerase inhibitor
0,145  0,006  Anticholelithogenic
0,171  0,033  Antibacterial (Helicobacter pylori)
0,218  0,081  Antiviral (West Nile virus)
0,272  0,136  GABA C receptor rho-3 antagonist
0,142  0,007  Granulocyte macrophage colony stimulating factor agonist
0,180  0,045  Aldose reductase substrate
0,250  0,118  Interleukin 2 agonist
0,153  0,022  Calcium antagonist
0,191  0,061  Muscle relaxant
0,134  0,004  Glucose-6-phosphate translocase inhibitor
0,135  0,005  Endocannabinoid uptake inhibitor
0,168  0,038  Aldehyde dehydrogenase inhibitor
0,142  0,014  Peroxisome proliferator-activated receptor gamma agonist
0,131  0,006  Plasminogen activator inhibitor antagonist
0,129  0,004  Catechol O-methyltransferase inhibitor
0,306  0,182  Antineoplastic (solid tumors)
0,135  0,012  Alcohol oxidase inhibitor
0,142  0,020  Phosphofructokinase-1 inhibitor
0,198  0,076  Antiviral (Influenza)
0,162  0,040  Farnesoid X receptor antagonist
0,136  0,015  CDC25A inhibitor
0,128  0,007  Carbonic anhydrase VII inhibitor
0,170  0,049  Cytokine production inhibitor
0,137  0,018  Cell adhesion molecule inhibitor
0,225  0,107  Immunostimulant
0,149  0,032  DNA repair enzyme inhibitor
0,168  0,053  Skeletal muscle relaxant
0,156  0,041  Adenylate cyclase inhibitor
0,122  0,007  GABA B receptor agonist
0,149  0,035  Papain-like protease (SARS coronavirus) inhibitor
0,242  0,129  Angiogenesis inhibitor
0,198  0,084  Age-related macular degeneration treatment
0,141  0,028  Creatine kinase inhibitor
0,127  0,015  ATPase (Vacuolar H+) inhibitor
0,148  0,035  Contraceptive female
0,128  0,016  Estrogen receptor alpha antagonist
0,135  0,024  Porphobilinogen synthase inhibitor
0,175  0,065  Thrombolytic
0,142  0,034  Caspase 3 inhibitor
0,149  0,042  Growth stimulant
0,154  0,047  Topoisomerase II inhibitor
0,137  0,031  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,140  0,035  Bronchodilator
0,149  0,044  Antiprotozoal (Amoeba)
0,216  0,113  5 Hydroxytryptamine 1E antagonist
0,189  0,086  Histone acetyltransferase inhibitor
0,107  0,005  Retinoid X alpha receptor agonist
0,140  0,038  Photosensitizer
0,124  0,022  Phosphodiesterase 6D inhibitor
0,110  0,009  Antiviral (Parainfluenza)
0,275  0,174  Antiarthritic
0,142  0,043  Antineoplastic (uterine cancer)
0,113  0,013  Estrogen-related receptor beta agonist
0,134  0,034  Gastric antisecretory
0,117  0,018  Thioredoxin reductase inhibitor
0,142  0,043  MAO A inhibitor
0,124  0,026  NADH dehydrogenase inhibitor
0,271  0,173  Transcription factor inhibitor
0,159  0,062  GABA C receptor rho-2 antagonist
0,166  0,069  Antiviral (Hepatitis C)
0,113  0,017  Hyperparathyroidism treatment
0,111  0,016  NMDA receptor agonist
0,124  0,028  Estrogen receptor beta antagonist
0,100  0,005  Retinoid X receptor agonist
0,138  0,043  Interleukin 8 antagonist
0,149  0,055  Cyclooxygenase 2 inhibitor
0,107  0,014  CDC25B inhibitor
0,111  0,018  SULT1A2 substrate
0,121  0,028  Antifungal (Aspergillus)
0,101  0,008  Aconitate hydratase inhibitor
0,104  0,011  Peroxisome proliferator-activated receptor alpha agonist
0,174  0,082  Antiviral (Hepatitis)
0,112  0,020  Leukotriene synthesis inhibitor
0,124  0,032  Alcohol dehydrogenase inhibitor
0,128  0,037  Electron transport complex I inhibitor
0,144  0,053  Antihelmintic (Trematoda)
0,133  0,045  Antiviral (Influenza B)
0,102  0,014  Antitreponemal
0,097  0,010  Exportin-1 inhibitor
0,271  0,184  Calcium channel L-type activator
0,112  0,025  Glutamate dehydrogenase inhibitor
0,113  0,027  Bile acid receptor antagonist
0,110  0,026  Myeloperoxidase inhibitor
0,131  0,047  Excitatory amino acid transporter EAAC1 inhibitor
0,106  0,023  D-Ala-D-Ala ligase inhibitor
0,117  0,034  Triose-phosphate isomerase inhibitor
0,092  0,009  Transcription factor RelA inhibitor
0,099  0,017  Maillard reaction inhibitor
0,114  0,032  Topoisomerase II alpha inhibitor
0,085  0,004  GABA transporter 3 inhibitor
0,134  0,053  Antiviral (Papilloma)
0,098  0,018  Estrogen agonist
0,100  0,021  Glycine receptor agonist
0,097  0,018  NMDA receptor glycine site agonist
0,083  0,005  Retinoic acid alpha receptor agonist
0,092  0,013  SULT2A1 substrate
0,115  0,037  Arylamine N-Acetyltransferase substrate
0,199  0,121  Neuropeptide Y2 antagonist
0,120  0,043  Adenylate kinase inhibitor
0,089  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,084  0,006  Factor III inhibitor
0,185  0,108  Antiviral (HIV)
0,220  0,144  Prostaglandin dehydrogenase inhibitor
0,112  0,036  SULT1E1 substrate
0,094  0,019  Prostaglandin antagonist
0,079  0,004  Kainate receptor agonist
0,137  0,064  Cocaine dependence treatment
0,083  0,010  Thromboxane synthase inhibitor
0,137  0,064  Acetylcholinesterase inhibitor
0,122  0,049  Antihelmintic (Fasciola)
0,162  0,090  Antineoplastic (gastric cancer)
0,075  0,004  Leukotriene B4 receptor 1 antagonist
0,089  0,019  Postmenopausal disorders treatment
0,091  0,021  Peroxisome proliferator-activated receptor gamma antagonist
0,076  0,007  Prostaglandin agonist
0,131  0,063  Cathepsin H inhibitor
0,119  0,051  HDL-cholesterol increasing
0,113  0,046  Anabolic
0,158  0,090  Myocardial ischemia treatment
0,127  0,060  Beta amyloid protein antagonist
0,081  0,014  Heme oxygenase stimulant
0,099  0,033  Na+ K+ transporting ATPase inhibitor
0,107  0,041  Antiviral (Rhinovirus)
0,118  0,051  Multidrug resistance-associated protein 1 inhibitor
0,126  0,060  Antineoplastic antimetabolite
0,075  0,010  Glucose-6-phosphate isomerase inhibitor
0,076  0,011  Vanilloid 2 antagonist
0,087  0,022  Purinergic P2X1 antagonist
0,106  0,041  Antifungal (Candida)
0,179  0,115  Aryl hydrocarbon receptor agonist
0,075  0,012  Ryanodine receptor antagonist
0,068  0,004  Retinoid X gamma receptor agonist
0,111  0,048  Sphingomyelinase inhibitor
0,072  0,010  Heparanase inhibitor
0,153  0,091  Antianginal
0,073  0,012  Leukotriene C antagonist
0,134  0,073  Bone formation stimulant
0,065  0,005  Retinoid X receptor antagonist
0,080  0,020  Prostaglandin E2 antagonist
0,143  0,084  Raynaud's phenomenon treatment
0,076  0,016  Postcoital contraceptive
0,081  0,022  Antimycoplasmal
0,112  0,053  Urease inhibitor
0,071  0,013  Pregnane X receptor antagonist
0,076  0,018  Phosphorylase inhibitor
0,134  0,076  Neurotrophic factor
0,062  0,004  Retinoid X beta receptor agonist
0,136  0,079  Cell wall synthesis inhibitor
0,115  0,058  Ferrochelatase inhibitor
0,063  0,006  Glutamate (mGluR8) agonist
0,177  0,121  ErbB-1 antagonist
0,143  0,087  Hexokinase inhibitor
0,134  0,079  Antiparkinsonian, tremor relieving
0,122  0,068  Sphingosine 1-phosphate receptor 4 antagonist
0,058  0,005  Retinoic acid receptor agonist
0,086  0,033  Selectin antagonist
0,059  0,006  Sodium-dependent vitamin C transporter 2 inhibitor
0,056  0,004  Retinoic acid alpha receptor antagonist
0,158  0,105  Antieczematic atopic
0,127  0,075  Toll-Like receptor antagonist
0,078  0,027  Antidote, heavy metal
0,079  0,028  Glutamate (mGluR7) antagonist
0,089  0,038  Cathepsin G inhibitor
0,068  0,018  DNA helicase inhibitor
0,128  0,079  Sphingosine 1-phosphate receptor 2 antagonist
0,108  0,059  GST T1-1 substrate
0,073  0,024  Thromboxane antagonist
0,124  0,075  Retinoprotector
0,056  0,007  Prostaglandin EP4 antagonist
0,053  0,005  Retinoid X alpha receptor antagonist
0,059  0,010  Fumarate hydratase inhibitor
0,069  0,022  Thromboxane A2 antagonist
0,097  0,049  Antidote, mercury
0,085  0,039  Histone deacetylase stimulant
0,085  0,039  Histone deacetylase SIRT1 stimulant
0,090  0,044  Metalloproteinase-2 inhibitor
0,050  0,004  Retinoic acid receptor antagonist
0,085  0,040  Metalloproteinase-9 inhibitor
0,062  0,018  Glutamate (mGluR group III) agonist
0,073  0,030  Biliverdin reductase inhibitor
0,063  0,020  Lysophosphatidic acid 3 receptor antagonist
0,062  0,019  Squalene epoxidase inhibitor
0,109  0,067  Acetylcholine release stimulant
0,093  0,051  Carcinogenic, group 2A
0,044  0,004  Retinoid X gamma receptor antagonist
0,046  0,007  Prostaglandin EP2 agonist
0,101  0,061  GABA C receptor rho-1 antagonist
0,149  0,109  Catenin beta inhibitor
0,100  0,061  UDP-glucose 4-epimerase inhibitor
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,045  0,006  Prostaglandin E2 agonist
0,062  0,024  Glycine transporter 2 inhibitor
0,120  0,082  CNS active muscle relaxant
0,097  0,059  Interleukin 12 antagonist
0,051  0,014  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,041  0,004  ICAM 1 antagonist
0,062  0,025  Adenine nucleotide translocase inhibitor
0,046  0,010  GABA transporter 2 inhibitor
0,066  0,030  Botulinum neurotoxin type A inhibitor
0,056  0,020  Adenylate cyclase 1 inhibitor
0,048  0,013  Peroxisome proliferator-activated receptor delta agonist
0,131  0,097  Antiviral (Herpes)
0,051  0,017  Dopamine D5 agonist
0,198  0,164  Thyroid hormone antagonist
0,080  0,046  Antibiotic
0,044  0,010  ATP citrate lysase inhibitor
0,047  0,013  Leukotriene C4 antagonist
0,094  0,060  Potassium channel (Ca-activated) activator
0,131  0,098  Sphingosine 1-phosphate receptor 5 antagonist
0,038  0,004  Retinoic acid gamma receptor agonist
0,041  0,008  LFA antagonist
0,088  0,055  Transcription factor NF kappa B stimulant
0,070  0,037  Protease 3C (Human rhinovirus) inhibitor
0,085  0,054  Inducible nitric-oxide synthase inhibitor
0,041  0,009  NMDA 2D receptor antagonist
0,049  0,018  Estrogen receptor alpha agonist
0,038  0,007  Prostaglandin H2 antagonist
0,130  0,100  Antifungal (Cryptococcus)
0,045  0,015  RNA-directed RNA polymerase inhibitor
0,069  0,040  Beta adrenoreceptor antagonist
0,066  0,037  Neuraminidase inhibitor
0,068  0,039  Neuraminidase (influenza) inhibitor
0,106  0,078  Anesthetic local
0,045  0,017  Cholesterol absorption inhibitor
0,043  0,016  Prostacyclin antagonist
0,043  0,015  Integrin alpha1beta1 antagonist
0,065  0,038  Carbamoyl phosphate synthetase inhibitor
0,031  0,005  Retinoic acid beta receptor agonist
0,038  0,012  Glutamate (mGluR3) agonist
0,043  0,017  Vanilloid 3 antagonist
0,089  0,063  Paget's disease treatment
0,137  0,111  Interleukin 6 antagonist
0,125  0,100  Antiviral (Influenza A)
0,081  0,056  Antineoplastic antibiotic
0,145  0,121  Psychostimulant
0,034  0,009  Thyroid hormone agonist
0,064  0,040  Prostaglandin F2 alpha antagonist
0,068  0,044  Glutamate (mGluR6) antagonist
0,059  0,036  Beta 1 adrenoreceptor antagonist
0,114  0,091  NADPH oxidase inhibitor
0,037  0,014  Lysophosphatidic acid 2 receptor antagonist
0,043  0,020  Farnesoid X receptor agonist
0,027  0,005  Retinoid X beta receptor antagonist
0,108  0,086  Retinopathy treatment
0,063  0,043  Nitric oxide donor
0,227  0,206  Antiparkinsonian
0,029  0,008  Inosine monophosphate dehydrogenase 2 inhibitor
0,099  0,079  GABA C receptor antagonist
0,045  0,026  Dihydrofolate reductase inhibitor
0,035  0,016  Prostaglandin D2 agonist
0,173  0,154  Antituberculosic
0,037  0,019  Tubulin agonist
0,040  0,022  Inosine monophosphate dehydrogenase inhibitor
0,044  0,027  Guanylate cyclase inhibitor
0,087  0,070  Glutamate release inhibitor
0,051  0,034  CD45 antagonist
0,048  0,031  Potassium channel Kv1.3 blocker
0,025  0,009  GABA transporter inhibitor
0,035  0,019  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,063  0,047  Beta 3 adrenoreceptor antagonist
0,036  0,021  HMG CoA reductase inhibitor
0,241  0,226  Alzheimer's disease treatment
0,019  0,004  Retinoic acid beta receptor antagonist
0,035  0,020  Estrogen-related receptor alpha antagonist
0,019  0,005  Integrin beta2 antagonist
0,030  0,016  Kynurenine 3 monooxygenase inhibitor
0,018  0,005  Glutamate (mGluR6) agonist
0,126  0,113  Neuropathy treatment
0,183  0,170  Thyroid hormone beta antagonist
0,025  0,013  Prostaglandin F2 alpha agonist
0,021  0,008  Antibiotic Trimethoprim-like
0,048  0,036  Topoisomerase II beta inhibitor
0,016  0,005  Retinoic acid receptor gamma antagonist
0,058  0,047  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,023  0,012  Integrin beta5 antagonist
0,028  0,017  Leukotriene D4 antagonist
0,116  0,105  Cytidine deaminase inhibitor
0,050  0,039  Matrix metalloproteinase 1 inhibitor
0,091  0,081  Glutamate (mGluR7) agonist
0,072  0,062  Narcotic antagonist
0,026  0,017  Methionyl aminopeptidase 2 inhibitor
0,047  0,038  Dopamine beta hydroxylase inhibitor
0,064  0,055  Elastase 1 inhibitor
0,039  0,031  Liver X receptor alpha agonist
0,018  0,009  Prostaglandin EP4 agonist
0,104  0,096  Transcription factor STAT6 inhibitor
0,015  0,007  Integrin alphaLbeta2 antagonist
0,061  0,054  Calcium channel P-type blocker
0,128  0,122  CF transmembrane conductance regulator agonist
0,032  0,027  Glutamate (mGluR4) agonist
0,033  0,027  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,030  0,025  Nucleoside transporters inhibitor
0,032  0,026  Peroxisome proliferator-activated receptor delta antagonist
0,087  0,082  Topoisomerase I inhibitor
0,033  0,027  Phosphoglycerate kinase inhibitor
0,037  0,032  GABA uptake inhibitor
0,085  0,081  Antiviral (Hepatitis A)
0,146  0,142  Antiparkinsonian, rigidity relieving
0,064  0,061  Lipase inhibitor
0,048  0,045  Acyl-CoA dehydrogenase inhibitor
0,132  0,130  Wound healing agent
0,022  0,020  Monocarboxylic acid transporter 1 inhibitor
0,022  0,020  Monocarboxylic acid transporter inhibitor
0,129  0,129  Movement disorders treatment
0,008  0,008  Thyroid hormone beta agonist
0,005  0,005  Insulin like growth factor 3 antagonist

